NL
SNOA icon

NWAM LLC’s Sonoma Pharmaceuticals SNOA Stock Holding History

NWAM LLC’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27
Closed -$23K – 262
2016
Q1 		$23K Hold
27
– – 0.01% 252
2015
Q4 		$28K Hold
27
– – 0.01% 255
2015
Q3 		$31K Hold
27
– – 0.03% 139
2015
Q2 		$34K Buy
+27
New +$25.3K 0.01% 246
2014
Q3 		– Sell
-42
Closed -$117K – 311
2014
Q2 		$117K Sell
42
-36
-46% -$107K 0.04% 287
2014
Q1 		$266K Buy
+78
New +$265K 0.09% 200

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

NWAM LLC's SNOA Position: Q2 2016 in Review

NWAM LLC sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2016, closing a stake of 27 shares — an estimated $23K sold.

NWAM LLC first reported a position in SNOA in Q1 2014 and held it in 6 quarters. The position peaked at $266K in Q1 2014. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2016.

  • NWAM LLC reported no remaining Sonoma Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • NWAM LLC sold 27 Sonoma Pharmaceuticals shares in Q2 2016, an estimated $23K.
  • NWAM LLC first reported a position in Sonoma Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • NWAM LLC's Sonoma Pharmaceuticals position peaked at $266K in Q1 2014.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2016.

Based on NWAM LLC's 13F filing for Q2 2016, filed 5 Aug 2016.